Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Relapsing Multiple Sclerosis · Relapsing Remitting Multiple Sclerosis · Secondary Progressive Multiple Sclerosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Stanford Multiple Sclerosis Center, Palo Alto, California, United States

    Contact: Study coordinator (Emma Martinez) · eam1@stanford.edu · 650-387-5907
    Contact: Principal Investigator (Jeffrey Dunn, MD, FAAN)
  • Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine, Aurora, Colorado, United States

    Contact: Study coordinator (Timber Bourassa, BS) · NeurologyResearchPartners@cuanschutz.edu · 303-724-8305
    Contact: Principal Investigator (John R. Corboy, MD)
  • Northwestern University, Evanston, Illinois, United States

    Contact: Study coordinator (Matthew Selle) · autoimmunesct@nm.org
    Contact: Principal Investigator (George Georges, MD)
    Contact: Principal Investigator (Bruce Cohen, MD)
  • University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

    Contact: Study coordinator (Irina Radu, MD, MHA) · irina.radu@umassmed.edu · 774-441-7754
    Contact: Principal Investigator (Carolina Ionete, MD, PhD)
  • University of Minnesota Multiple Sclerosis Center, Minneapolis, Minnesota, United States

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Lisa Roemer) · Roemer.Lisa@mayo.edu · 507-293-9754
    Contact: Principal Investigator (B. Mark Keegan, MD,FRCPC)
  • John L. Trotter Multiple Sclerosis Center, Washington University School of Medicine in St. Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Laura Teeter) · lteeter@wustl.edu · 314-747-6247
    Contact: Principal Investigator (Gregory Wu, MD, PhD)
  • Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Siinai, New York, New York, United States

    Contact: Study coordinator (Susan Filomena) · susan.e.filomena@mssm.edu · 212-241-3841
    Contact: Principal Investigator (Aaron Miller, MD)
  • Rochester Multiple Sclerosis Center, University of Rochester, Rochester, New York, United States

    Contact: Principal Investigator (Andrew D. Goodman, MD)
  • Duke University Medical Center, Durham, North Carolina, United States

  • University of Cincinnati (UC) Waddell Center for Multiple Sclerosis, Cincinnati, Ohio, United States

    Contact: Study coordinator (Tiffany Rupert, CCRC) · BEATMSResearch@UCHealth.com · 513-558-0269
    Contact: Principal Investigator (Aram Zabeti, MD)
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Alecia Chase) · chasea@ccf.org · 216-780-4935
    Contact: Principal Investigator (Jeffrey A. Cohen, MD)
  • Multiple Sclerosis Center, Oregon Health & Science University, Portland, Oregon, United States

    Contact: Study coordinator (Debbie Guess, RN) · griffide@ohsu.edu · 503-494-7651
    Contact: Principal Investigator (Yadav Vijayshree, MD,MCR,FANA,FAAN)
  • Penn Comprehensive MS Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (MS MS Clinical Research Team) · msresearch@pennmedicine.upenn.edu · 215-906-4778
    Contact: Principal Investigator (Amit Bar-Or, MD,FRCP,FAAN,FANA)
  • University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology, Dallas, Texas, United States

    Contact: Study coordinator (Manual Huichapa) · manuel.huichapa@utsoutwestern.edu · 214-645-8216
    Contact: Principal Investigator (Benjamin Greenberg, MD)
  • Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center, Houston, Texas, United States

    Contact: Study coordinator (Tahari Griffin) · tgriffin@bcm.edu · 713-798-6097
    Contact: Principal Investigator (George J. Hutton, MD)
  • University of Virginia, Charlottesville, Virginia, United States

    Contact: Study coordinator (Matthew Baron) · ukx3sv@uvahealth.org · 434-297-4102
    Contact: Principal Investigator (Mini Singh, MD)
  • Virginia Commonwealth University Multiple Sclerosis Treatment and Research Center, Richmond, Virginia, United States

    Contact: Study coordinator (Unsong Oh, MD) · unsong.oh@vcuhealth.org · 804-828-3067
    Contact: Principal Investigator (Unsong Oh, MD)
  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

    Contact: Study coordinator (Bernadette McLaughlin) · bmclaugh@fredhutch.org · 206-667-4916
    Contact: Principal Investigator (Leona Holmberg, MD, PhD)
  • Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, Washington, United States

    Contact: Study coordinator (Bernadette McLaughlin) · bmclaugh@fredhutch.org · 206-667-4916
    Contact: Principal Investigator (James D. Bowen, MD)
  • Multiple Sclerosis Center at Northwest Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Bernadette McLaughlin) · bmclaugh@fredhutch.org · 206-667-4916
    Contact: Principal Investigator (Annette Wundes, MD)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Pam Dailey) · pdailey@mcw.edu · 262-689-1846
    Contact: Principal Investigator (Ahmed Obeidat, M.D.)
מובילי המחקר
  • Jeffrey A. Cohen, MD

    Study Chair

    Mellen Center for MS Treatment and Research, Cleveland Clinic

  • George E. Georges, MD

    Study Chair

    Northwestern University

  • Paolo A. Muraro, MD, PhD

    Study Chair

    Department of Medicine, Imperial College London